Takeda Pharmaceutical (TAK) Asset Utilization Ratio (2019 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Asset Utilization Ratio of 0.47 for Q2 2026, down 2.84% year-over-year from 0.49 in Q2 2025, and up 0.95% quarter-over-quarter from 0.47 in Q1 2026.
Takeda Pharmaceutical (TAK) Asset Utilization Ratio (2019 - 2026) Analysis & Trends
Takeda Pharmaceutical's Asset Utilization Ratio history runs 8 years deep, the most recent figure standing at 0.47 for Q2 2026.
- In Q2 2026, Asset Utilization Ratio fell 2.84% year-over-year to 0.47; the TTM figure through Jun 2026 stood at 0.47 (down 2.84% YoY), while the FY2026 annual figure was 0.3, changed 0.39% from the prior year.
- Asset Utilization Ratio for Q2 2026 stood at 0.47, up from 0.47 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.49 in Q2 2025, with the low at 0.28 in Q2 2022.
- The 5-year median for Asset Utilization Ratio is 0.45 (2023), against an average of 0.41.
- The sharpest annual moves came in 2024 and 2026: Asset Utilization Ratio soared 52.42% in 2024, then declined 2.84% in 2026.
- Takeda Pharmaceutical's Asset Utilization Ratio stood at 0.31 in 2022, then soared by 47.35% to 0.45 in 2023, then advanced by 4.24% to 0.47 in 2024, then decreased by 0.36% to 0.47 in 2025, then increased by 0.29% to 0.47 in 2026.
- Business Quant data shows TAK's Asset Utilization Ratio at 0.47 in Q2 2026, 0.47 in Q1 2026, and 0.47 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 0.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.47 |
| Mar 31, 2026 | 0.47 |
| Dec 31, 2025 | 0.47 |
| Sep 30, 2025 | 0.48 |
| Jun 30, 2025 | 0.49 |
| Mar 31, 2025 | 0.48 |
| Dec 31, 2024 | 0.47 |
| Sep 30, 2024 | 0.46 |
| Jun 30, 2024 | 0.44 |
| Mar 31, 2024 | 0.46 |
| Dec 31, 2023 | 0.45 |
| Sep 30, 2023 | 0.43 |
| Jun 30, 2023 | 0.29 |
| Mar 31, 2023 | 0.30 |
| Dec 31, 2022 | 0.31 |
| Sep 30, 2022 | 0.29 |
| Jun 30, 2022 | 0.28 |
| Mar 31, 2022 | 0.29 |
| Dec 31, 2021 | 0.28 |
| Sep 30, 2021 | 0.28 |